Hello Avatar! Welcome back for another week of biotech market analysis. Relief price action continues from last week as BOTH the broader markets and biotech continue their rally. Are we back in business? We think not, particularly as the US FED continues it Hawkish rhetoric.
As a reminder, the purpose of the BowTiedBiotech substack is two-fold. Prima…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.